Objective : Symptoms of posterior reversible encephalopathy syndrome (PRES) include headache, altered mental status, visual disturbances, and seizures. Typical radiological features include edema of the parieto-occipital lobes. The purpose of this study is to review the clinical and radiological findings in patients diagnosed with PRES.
INTRODUCTION

Posterior reversible encephalopathy syndrome (PRES)
is a clinico-radiological entity characterized by a varying combination of symptoms and signs that include impaired consciousness, seizure activity, headache, visual abnormalities, nausea/vomiting, and focal neurological deficits. by Hinchey and colleagues in 1996. 16) The syndrome is characterized by a primarily vasogenic edema of the subcortical white matter with a predilection for the parenchyma supplied by the posterior circulation, and is potentially reversible. 4) However, recognition of atypical imaging findings, such as varied distribution patterns, cytotoxic edema, infarction, hemorrhage, and contrast enhancement has recently increased.
15)32)
However, many patients are still not diagnosed during the initial stage. Studies have reported on precipitants of PRES, such as hypertension, acute renal failure, eclampsia, blood transfusion, infection, sepsis, radio-contrast, and immunosuppressive agents, and certain cytotoxic medications. PRES must be taken into consideration; radiological studies, particularly magnetic resonance imaging (MRI), should be performed.
Without immediate diagnosis and administration of appropriate treatment, which have the greatest effect on prognosis, progression to ischemia, infarction, and death might occur.
The aim of this study is to identify the clinical and radiological findings of all patients who were admitted to our institution with a diagnosis of PRES, and to review the current literature on this syndrome.
MATERIALS AND METHODS
The radiological report data bases, involving the neu- 
RESULTS
Clinical findings
We identified 16 patients (10 females and 6 males).
Mean age at presentation was 47 ± 21.6 years (range, 
Radiological findings
All patients underwent initial neuroimaging with either brain CT scan (n = 5) or MRI (n = 11). Several topographic MR imaging patterns of PRES have been described (Fig. 1) . 4) Bilateral cerebral subcortical white matter involvement was observed in all patients.
Parietal lobe involvement was observed in 13 (81.3%) patients (81.8%) had hypo-or isointensity on DWI.
On the ADC map, 10 patients (90.9%) had hyperintensity, and the other had normal values. Two patients had intracranial hemorrhage. The radiological spectrum of lesion distribution of 16 patients with PRES was described in Table 2 .
Treatment
We performed symptomatic treatment and control Clinical recovery occurred within a mean duration of 5.7 ± 4.6 days (range, 2-15). Clinical characteristics in 16 patients with PRES are described in Table 1 .
DISCUSSION
A unique pattern of brain vasogenic edema seen in the setting of neurotoxicity has been recognized as PRES associated with eclampsia, cyclosporine after organ transplantation, and severe hypertension. PRES without hypertension is reported in 20-40% of patients. [4] [5] [6] In the majority of cases, although hypertension (moderate to severe) is present, reported blood pressure at neurotoxicity does not reach the limit of autoregulation. showed acute elevation of blood pressure.
Considering the common major conditions associated with development of PRES, such as transplantation, autoimmune disease, preeclampsia/eclampsia, cancer chemotherapy, infection and sepsis, some degree of endothelial injury appears to be a consistent finding.
4)10)
In our study, PRES was observed in association with a wide range of disorders and predisposing conditions, ranging from hypertension, eclampsia to sepsis, subarachnoid hemorrhage, and exposure to cytotoxic drugs as well as Behcet diseases.
Association of high-dose multidrug cytotoxic chemotherapy with PRES, particularly in children with leukemia, has also been reported. 9) In additionally, PRES has been reported in association with the following chemotherapeutic drugs: cytarabine, cisplatin, gemcitabine, and bevacizumab. However, frequent frontal lobe involvement, rather than atypical localization, has recently been described.
Therefore, the hypothesis of less sympathetic in- 
CONCLUSION
We suggest that PRES can occur in patients with complex systemic conditions. The prognosis of PRES is usually benign. Although it is a well-known condition among neuroradiologists, many physicians working in critical areas are still not familiar with PRES. Physicians should be aware of atypical radiological findings to avoid a delayed diagnosis of PRES, as delayed diagnosis and treatment can result in permanent neurological sequlae.
